RecruitingNCT06563414
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
Sponsor
Krystal Biotech, Inc.
Enrollment
40 participants
Start Date
Aug 2, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a non-interventional, observational study that will evaluate the natural history of corneal abrasions in patients with Dystrophic Epidermolysis Bullosa (DEB).
Eligibility
Min Age: 6 Months
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with epidermolysis bullosa dystrophica, epidermolysis bullosa dystrophica dominans, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Months and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06563414
Related Trials
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT010191481 location
GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
NCT071931341 location
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT061773532 locations